The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions.
about
The use of lorcaserin in the management of obesity: a critical appraisalProteome changes in rat plasma in response to sibutramine.Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs.Pharmacological approaches for management of child and adolescent obesityClinical and economic considerations of antiobesity treatment: a review of orlistatComparative efficiency and safety of pharmacological approaches to the management of obesity.Do we need anti-obesity drugs?Therapeutic options for binge eating disorder.[Recent progress and novel perspectives on obesity pharmacotherapy].A comparative study of five centrally acting drugs on the pharmacological treatment of obesity.Single dose and repeated administrations of liraglutide alter energy metabolism in the brains of young and adult rats.
P2860
Q24594774-0CA548C9-2393-4DEC-94BE-F26102E33C9DQ33825506-0CDC6997-3EE8-4AEE-9D5E-7C83289C979AQ33916086-98F01A7B-C795-40C5-B40C-C743E9D23102Q35015326-32EF29B2-AD32-423D-9964-85A27DF04580Q35205363-85093969-9D3D-4E54-9A62-C722BB1B88C6Q36783891-DEF45835-958A-46F7-AE42-193D3F2C4794Q38071006-67758AB6-8050-492C-8C9C-99A53BB4A020Q38113754-95FCC2CC-B609-4935-99D2-0969762F1D26Q42881681-259B3103-67B7-4F24-9146-7E6260DD70FBQ46186166-3274B7B2-880B-4F7B-BFAA-4031AA1200D5Q48550172-72AB3BA7-2AEF-418A-BB16-1C280C04C872
P2860
The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The first decade of sibutramin ...... ity and associated conditions.
@en
The first decade of sibutramin ...... ity and associated conditions.
@nl
type
label
The first decade of sibutramin ...... ity and associated conditions.
@en
The first decade of sibutramin ...... ity and associated conditions.
@nl
prefLabel
The first decade of sibutramin ...... ity and associated conditions.
@en
The first decade of sibutramin ...... ity and associated conditions.
@nl
P2860
P1476
The first decade of sibutramin ...... ity and associated conditions.
@en
P2093
Walmir Coutinho
P2860
P304
P356
10.1590/S0004-27302009000200018
P577
2009-03-01T00:00:00Z